vs

Side-by-side financial comparison of HomeTrust Bancshares, Inc. (HTB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $53.6M, roughly 1.6× HomeTrust Bancshares, Inc.). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 3.5%).

HomeTrust Bancshares Inc. is an Asheville, North Carolina–based bank holding company with $4.3 billion in assets and 33 branches in North and South Carolina, Georgia and Tennessee. It is the parent of seven community banks—HomeTrust Bank, Tryon Federal Bank, Shelby Savings Bank, Home Savings Bank, Industrial Federal Bank, Cherryville Federal Bank and Rutherford County Bank.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

HTB vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.6× larger
PRCT
$83.1M
$53.6M
HTB
Growing faster (revenue YoY)
PRCT
PRCT
+16.5% gap
PRCT
20.2%
3.7%
HTB
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
3.5%
HTB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HTB
HTB
PRCT
PRCT
Revenue
$53.6M
$83.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
37.0%
-4.1%
Net Margin
-38.1%
Revenue YoY
3.7%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.93
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTB
HTB
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$53.6M
$76.4M
Q3 25
$54.1M
$83.3M
Q2 25
$54.4M
$79.2M
Q1 25
$50.9M
$69.2M
Q4 24
$51.7M
$68.2M
Q3 24
$50.6M
$58.4M
Q2 24
$50.6M
$53.4M
Net Profit
HTB
HTB
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$16.5M
$-21.4M
Q2 25
$17.2M
$-19.6M
Q1 25
$14.5M
$-24.7M
Q4 24
$-18.9M
Q3 24
$13.1M
$-21.0M
Q2 24
$12.4M
$-25.6M
Gross Margin
HTB
HTB
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
HTB
HTB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
37.0%
-40.6%
Q3 25
38.5%
-27.8%
Q2 25
40.1%
-28.0%
Q1 25
36.2%
-39.7%
Q4 24
35.4%
-28.9%
Q3 24
33.2%
-38.4%
Q2 24
31.3%
-50.3%
Net Margin
HTB
HTB
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
30.5%
-25.7%
Q2 25
31.6%
-24.7%
Q1 25
28.5%
-35.8%
Q4 24
-27.6%
Q3 24
25.9%
-35.9%
Q2 24
24.6%
-48.0%
EPS (diluted)
HTB
HTB
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.93
$-0.54
Q3 25
$0.95
$-0.38
Q2 25
$1.00
$-0.35
Q1 25
$0.84
$-0.45
Q4 24
$0.83
$-0.34
Q3 24
$0.76
$-0.40
Q2 24
$0.73
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTB
HTB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$324.7M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$600.7M
$347.7M
Total Assets
$4.5B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTB
HTB
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$324.7M
$286.5M
Q3 25
$315.8M
$294.3M
Q2 25
$297.2M
$302.7M
Q1 25
$299.8M
$316.2M
Q4 24
$279.2M
$333.7M
Q3 24
$293.5M
$196.8M
Q2 24
$294.2M
$214.1M
Total Debt
HTB
HTB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
HTB
HTB
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$600.7M
$365.9M
Q3 25
$595.8M
$380.3M
Q2 25
$579.3M
$385.8M
Q1 25
$565.4M
$389.2M
Q4 24
$551.8M
$402.2M
Q3 24
$540.0M
$241.2M
Q2 24
$523.6M
$251.8M
Total Assets
HTB
HTB
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$4.5B
$508.1M
Q3 25
$4.6B
$511.5M
Q2 25
$4.6B
$513.1M
Q1 25
$4.6B
$519.4M
Q4 24
$4.6B
$534.0M
Q3 24
$4.6B
$374.1M
Q2 24
$4.7B
$374.4M
Debt / Equity
HTB
HTB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTB
HTB
PRCT
PRCT
Operating Cash FlowLast quarter
$49.5M
Free Cash FlowOCF − Capex
$45.3M
FCF MarginFCF / Revenue
84.5%
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$93.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTB
HTB
PRCT
PRCT
Q1 26
Q4 25
$49.5M
$-10.3M
Q3 25
$-11.3M
$-6.6M
Q2 25
$-8.8M
$-15.0M
Q1 25
$71.7M
$-17.0M
Q4 24
$45.4M
$-32.4M
Q3 24
$43.8M
$-18.8M
Q2 24
$5.9M
$-15.7M
Free Cash Flow
HTB
HTB
PRCT
PRCT
Q1 26
Q4 25
$45.3M
$-12.2M
Q3 25
$-12.0M
$-9.5M
Q2 25
$-10.2M
$-17.8M
Q1 25
$70.7M
$-18.8M
Q4 24
$42.4M
$-33.6M
Q3 24
$43.1M
$-19.0M
Q2 24
$5.7M
$-16.8M
FCF Margin
HTB
HTB
PRCT
PRCT
Q1 26
Q4 25
84.5%
-15.9%
Q3 25
-22.2%
-11.4%
Q2 25
-18.7%
-22.5%
Q1 25
138.7%
-27.2%
Q4 24
82.0%
-49.2%
Q3 24
85.1%
-32.6%
Q2 24
11.2%
-31.4%
Capex Intensity
HTB
HTB
PRCT
PRCT
Q1 26
Q4 25
7.8%
2.4%
Q3 25
1.4%
3.4%
Q2 25
2.5%
3.5%
Q1 25
2.0%
2.7%
Q4 24
5.9%
1.7%
Q3 24
1.3%
0.4%
Q2 24
0.5%
2.0%
Cash Conversion
HTB
HTB
PRCT
PRCT
Q1 26
Q4 25
Q3 25
-0.68×
Q2 25
-0.51×
Q1 25
4.93×
Q4 24
Q3 24
3.34×
Q2 24
0.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTB
HTB

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons